Quality by design modelling to support rapid RNA vaccine production against emerging infectious diseases.
Quality by design modelling to support rapid RNA vaccine production against emerging infectious diseases.
复制标题
DOI:
10.1038/s41541-021-00322-7
复制
发表时间:
2021-04-29
期刊:
影响因子:
9.2
通讯作者:
Shah N
中科院分区:
文献类型:
--
作者:
van de Berg D;Kis Z;Behmer CF;Samnuan K;Blakney AK;Kontoravdi C;Shattock R;Shah N
Rapid-response vaccine production platform technologies, including RNA vaccines, are being developed to combat viral epidemics and pandemics. A key enabler of rapid response is having quality-oriented disease-agnostic manufacturing protocols ready ahead of outbreaks. We are the first to apply the Quality by Design (QbD) framework to enhance rapid-response RNA vaccine manufacturing against known and future viral pathogens. This QbD framework aims to support the development and consistent production of safe and efficacious RNA vaccines, integrating a novel qualitative methodology and a quantitative bioprocess model. The qualitative methodology identifies and assesses the direction, magnitude and shape of the impact of critical process parameters (CPPs) on critical quality attributes (CQAs). The mechanistic bioprocess model quantifies and maps the effect of four CPPs on the CQA of effective yield of RNA drug substance. Consequently, the first design space of an RNA vaccine synthesis bioreactor is obtained. The cost-yield optimization together with the probabilistic design space contribute towards automation of rapid-response, high-quality RNA vaccine production.
登录
查看更多内容
DOI:
10.1038/nrd.2017.243
发表时间:
2018-04
期刊:
Nature reviews. Drug discovery
影响因子:
--
作者:
Pardi N;Hogan MJ;Porter FW;Weissman D
通讯作者:
Weissman D
影响因子:
15
作者:
Li, YF;Breaker, RR
通讯作者:
Breaker, RR
DOI:
10.1007/978-1-62703-625-2_16
发表时间:
2013-01-01
期刊:
SYNTHETI C BIOLOGY
影响因子:
--
作者:
Kucherenko, Sergei
通讯作者:
Kucherenko, Sergei
影响因子:
5.5
作者:
Bernhardt HS;Tate WP
通讯作者:
Tate WP
影响因子:
14.9
作者:
FRUGIER, M;FLORENTZ, C;GIEGE, R
通讯作者:
GIEGE, R